We are live on
!
Find out more
KC
Kades & Cheifetz Portfolio holdings
AUM
$195M
1-Year Est. Return
11.87%
This Fund
S&P 500
This Quarter
Est. Return
+4.37%
1 Year Est. Return
+11.87%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$156M
AUM Growth
+$15.1M
(+11%)
Cap. Flow
+$9.62M
Cap. Flow
% of AUM
6.16%
Top 10 Holdings %
Top 10 Hldgs %
47.92%
Holding
90
New
10
Increased
51
Reduced
27
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Shares Nasdaq 7HANDL Index ETF
HNDL
|
+$4.35M |
| 2 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$1.82M |
| 3 |
Vanguard Short-Term Tax-Exempt Bond ETF
VTES
|
+$1.81M |
| 4 |
Matthews Emerging Markets ex China Active ETF
MEMX
|
+$1.02M |
| 5 |
Schwab 1-5 Year Corporate Bond ETF
SCHJ
|
+$468K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
|
+$1.87M |
| 2 |
Schwab Emerging Markets Equity ETF
SCHE
|
+$558K |
| 3 |
State Street SPDR S&P International Dividend ETF
DWX
|
+$303K |
| 4 |
NVIDIA
NVDA
|
+$181K |
| 5 |
WisdomTree US SmallCap Dividend Fund
DES
|
+$163K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.09% |
| 2 | Healthcare | 1.46% |
| 3 | Industrials | 1.46% |
| 4 | Communication Services | 0.99% |
| 5 | Consumer Staples | 0.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Amgen
AMGN
$209B
| $287K | 0.18% |
1,010
+201
| +25% | +$58.8K |
|
77
Overlay Shares Hedged Large Cap Equity ETF
OVLH
$115M
| $284K | 0.18% |
9,094
+643
| +8% | +$19.3K |
|
78
Intuitive Surgical
ISRG
$126B
| $267K | 0.17% |
669
-12
| -2% | -$4.53K |
|
79
Vanguard ESG US Stock ETF
ESGV
$13.1B
| $247K | 0.16% |
2,655
| – | – |
|
|
SCHR
80
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
| $229K | 0.15% |
+9,320
| New | +$229K |
|
81
Merck
MRK
$321B
| $222K | 0.14% |
+1,681
| New | +$207K |
|
82
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.83B
| $215K | 0.14% |
5,336
+14
| +0.3% | +$533 |
|
83
Costco
COST
$423B
| $212K | 0.14% |
+290
| New | +$207K |
|
84
Invesco Water Resources ETF
PHO
$2B
| $210K | 0.13% |
+3,160
| New | +$196K |
|
85
Enterprise Products Partners
EPD
$82.5B
| $210K | 0.13% |
+7,201
| New | +$198K |
|
86
Procter & Gamble
PG
$335B
| $202K | 0.13% |
+1,247
| New | +$196K |
|
87
SPDR Gold Trust
GLD
$133B
| $201K | 0.13% |
+976
| New | +$187K |
|
|
HDV
88
iShares Core High Dividend ETF
HDV
$14.5B
| $200K | 0.13% |
+9,095
| New | +$191K |
|
89
Ford
F
$59.3B
| $140K | 0.09% |
10,522
-9,959
| -49% | -$121K |
|
90
Arbutus Biopharma
ABUS
$871M
| $51.6K | 0.03% |
20,000
| – | – |
|
Similar funds
SL
QS
HPFG
LHR
CM
AJ
KWM
HFS
Kades & Cheifetz's Q1 2024 Portfolio in Review
As of Q1 2024, Kades & Cheifetz held 90 positions worth $156M, up 11% from $141M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Kades & Cheifetz deployed $9.62M of net new capital in Q1 2024, opening 10 new positions and adding to 51 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ex China ETF: 32,774 shares worth $1.89M.
By sector, the portfolio is most concentrated in Technology at 8.1% of assets, down from 8.8% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was State Street SPDR Nuveen ICE Short Term Municipal Bond ETF, an estimated $1.87M trimmed.
- Kades & Cheifetz's largest Q1 2024 buy was iShares MSCI Emerging Markets ex China ETF: 32,774 shares worth $1.89M.
- Kades & Cheifetz added most to Strategy Shares Nasdaq 7HANDL Index ETF in Q1 2024, an estimated $4.35M increase.
- Kades & Cheifetz's biggest Q1 2024 reduction was State Street SPDR Nuveen ICE Short Term Municipal Bond ETF, cutting an estimated $1.87M.
- Kades & Cheifetz's ten largest holdings make up 48% of its $156M portfolio in Q1 2024.
- Kades & Cheifetz opened 10 new positions and closed 0 in Q1 2024.
- Kades & Cheifetz's portfolio value rose 11% quarter-over-quarter to $156M.
Based on Kades & Cheifetz's 13F filing for Q1 2024, filed 6 May 2024.